Your session is about to expire
← Back to Search
Brain Imaging for Chronic Pain and Fatigue
N/A
Waitlist Available
Led By Roland Staud, MD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
diagnosis of ME/CFS will require a history of chronic fatigue persisting or relapsing for more than 6 months as well as the presence of at least four out of eight designated symptoms.
Diagnosis of ME/CFS will require a history of chronic fatigue persisting or relapsing for more than 6 months as well as the presence of at least four out of eight designated symptoms.
Must not have
Patients unwilling or unable to discontinue or modify analgesics, hypnotics, anxiolytics, or anti-depressants during the study period will be excluded from this trial.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 intervals of 30 seconds each
Awards & highlights
No Placebo-Only Group
Summary
This trial will use functional brain imaging to study central factors of chronic pain and fatigue, in order to better understand and treat these disorders.
Who is the study for?
This trial is for individuals with chronic pain and fatigue conditions like Fibromyalgia (FM) or Chronic Fatigue Syndrome (ME/CFS). Participants must have had symptoms persisting for over 6 months, meet specific criteria for tender points in FM, or certain symptom counts in ME/CFS. They should be willing to lower their antidepressant doses substantially.
What is being tested?
The study uses functional magnetic resonance imaging (fMRI) to investigate brain and spinal cord abnormalities that may contribute to chronic pain and fatigue. It aims to understand the central mechanisms behind these conditions by observing how the nervous system functions during sensory testing.
What are the potential side effects?
Since this trial involves non-invasive imaging techniques like fMRI and sensory testing devices rather than drugs, side effects are minimal but can include discomfort from lying still during scans or temporary sensations from sensory tests.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had chronic fatigue for over 6 months and at least four related symptoms.
Select...
I have had chronic fatigue for over 6 months and at least four specific symptoms.
Select...
I have been diagnosed with fibromyalgia and have widespread pain and tenderness in many areas.
Select...
I have been diagnosed with fibromyalgia and have widespread pain and at least 11 tender points.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am willing and able to adjust my pain, sleep, anxiety, or depression medications for the study.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 intervals of 30 seconds each
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 intervals of 30 seconds each
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in experimental Pain from mechanical stimulation to the upper extremities and the shoulder
Change in experimental pain from heat pulses to the upper extremities
Secondary study objectives
Change in Fatigue Ratings
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Group I: Healthy ControlExperimental Treatment3 Interventions
normal volunteers (HC) Undergoing sensory testing, brain and spinal cord neuroimaging and Inventory assessments.
Group II: Fibromyalgia OnlyExperimental Treatment3 Interventions
The diagnosis of FM will require a history of chronic widespread pain as well as the presence of at least eleven out of eighteen paired tender points. Undergoing sensory testing, brain and spinal cord neuroimaging and Inventory assessments.
Group III: Chronic fatigue and Fibromyalgia SyndromeExperimental Treatment3 Interventions
Diagnosis of ME/CFS will require a history of chronic fatigue persisting or relapsing for more than 6 months as well as the presence of at least four out of eight designated symptoms. Undergoing sensory testing, brain and spinal cord neuroimaging and Inventory assessments.
Find a Location
Who is running the clinical trial?
University of FloridaLead Sponsor
1,409 Previous Clinical Trials
767,262 Total Patients Enrolled
Roland Staud, MDPrincipal InvestigatorUniversity of Florida
4 Previous Clinical Trials
246 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had chronic fatigue for over 6 months and at least four related symptoms.I am willing to lower my antidepressant doses as required.I am willing and able to adjust my pain, sleep, anxiety, or depression medications for the study.I have had chronic fatigue for over 6 months and at least four specific symptoms.I have been diagnosed with fibromyalgia and have widespread pain and tenderness in many areas.I am willing to lower my antidepressant doses for the trial.I have been diagnosed with fibromyalgia and have widespread pain and at least 11 tender points.
Research Study Groups:
This trial has the following groups:- Group 1: Fibromyalgia Only
- Group 2: Chronic fatigue and Fibromyalgia Syndrome
- Group 3: Healthy Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.